Comment on “Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study”

Florenzo Iannone; Elisa Gremese; Gianfranco Ferraccioli; Giovanni Lapadula

doi:10.1007/s10067-015-2997-8

Comment on “Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study”

Florenzo Iannone, Elisa Gremese, Gianfranco Ferraccioli, Giovanni Lapadula

Rheumatology Unit

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. [Clin Rheumatol. 2015]

Lingua originale	English
pagine (da-a)	839-840
Numero di pagine	2
Rivista	Clinical Rheumatology
Volume	35
DOI	https://doi.org/10.1007/s10067-015-2997-8
Stato di pubblicazione	Pubblicato - 2016

Keywords

Adalimumab
Antirheumatic Agents
Arthritis, Rheumatoid
Chemical and Drug Induced Liver Injury
Etanercept
Female
Hepatitis C, Chronic
Humans
Male
Rheumatology

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1007/s10067-015-2997-8

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{228dfe56892340f1905d2ebeb6016e8f,

title = "Comment on “Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study”",

abstract = "Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. [Clin Rheumatol. 2015]",

keywords = "Adalimumab, Antirheumatic Agents, Arthritis, Rheumatoid, Chemical and Drug Induced Liver Injury, Etanercept, Female, Hepatitis C, Chronic, Humans, Male, Rheumatology, Adalimumab, Antirheumatic Agents, Arthritis, Rheumatoid, Chemical and Drug Induced Liver Injury, Etanercept, Female, Hepatitis C, Chronic, Humans, Male, Rheumatology",

author = "Florenzo Iannone and Elisa Gremese and Gianfranco Ferraccioli and Giovanni Lapadula",

year = "2016",

doi = "10.1007/s10067-015-2997-8",

language = "English",

volume = "35",

pages = "839--840",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "-Heidelberg : Springer, -Brussels : Acta Medica Belgica, [1982-",

}

TY - JOUR

T1 - Comment on “Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study”

AU - Iannone, Florenzo

AU - Gremese, Elisa

AU - Ferraccioli, Gianfranco

AU - Lapadula, Giovanni

PY - 2016

Y1 - 2016

N2 - Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. [Clin Rheumatol. 2015]

AB - Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study. [Clin Rheumatol. 2015]

KW - Adalimumab

KW - Antirheumatic Agents

KW - Arthritis, Rheumatoid

KW - Chemical and Drug Induced Liver Injury

KW - Etanercept

KW - Female

KW - Hepatitis C, Chronic

KW - Humans

KW - Male

KW - Rheumatology

KW - Adalimumab

KW - Antirheumatic Agents

KW - Arthritis, Rheumatoid

KW - Chemical and Drug Induced Liver Injury

KW - Etanercept

KW - Female

KW - Hepatitis C, Chronic

KW - Humans

KW - Male

KW - Rheumatology

UR - http://hdl.handle.net/10807/94108

U2 - 10.1007/s10067-015-2997-8

DO - 10.1007/s10067-015-2997-8

M3 - Article

SN - 0770-3198

VL - 35

SP - 839

EP - 840

JO - Clinical Rheumatology

JF - Clinical Rheumatology

ER -

Comment on “Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study”

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo